SU5416 (semaxanib)

semaxanib · Sugen Inc. (acquired by Pharmacia)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SU5416 (semaxanib), covering 2009-12-04 to 2013-06-03. Get the full timeline:

Most recent: Clinical Trial Update: SU5416 in Treating Patients With Malignant Mesothelioma [Phase 2]